Advertisement
Screener

Instil Bio, Inc. (TIL) Graph

TIL Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2026-06-30: Revenue (m); Research and development (m); Operating expenses $5.58M; Income tax (m).
  • 2026-03-31: Revenue (m); Research and development (m); Operating expenses $7.01M; Income tax (m).
  • 2025-12-31: Revenue (m); Research and development (m); Operating expenses $9.56M*; Income tax (m).
  • 2025-09-30: Revenue (m); Research and development (m); Operating expenses $15.02M; Income tax (m).

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30(m)(m)$5.58M(m)-$4.30M
2026-03-31(m)(m)$7.01M(m)-$4.20M
2025-12-31(m)(m)$9.56M*(m)-$8.19M*
2025-09-30(m)(m)$15.02M(m)-$13.59M
2025-06-30(m)(m)$23.44M(m)-$21.39M
2025-03-31(m)(m)$30.56M(m)-$28.20M
2024-09-30(m)(m)$23.63M(m)-$23.02M
2024-06-30(m)$2.92M$14.13M(m)-$14.92M
2024-03-31(m)$7.26M$23.95M(m)-$24.30M
2023-12-31(m)$1.98M*(m)$0.00*(m)
2023-09-30(m)$8.49M$66.72M$0.00-$67.43M
2023-06-30(m)$8.46M$20.99M$0.00-$18.66M
2023-03-31(m)$20.67M$58.45M$0.00-$57.07M
2022-09-30(m)$39.66M$56.65M-$371.00K-$56.22M
2022-06-30(m)$41.50M$58.72M-$609.00K-$58.99M
2022-03-31(m)$39.17M$54.29M-$488.00K-$54.12M
2021-12-31$0.00*(m)(m)(m)(m)
2021-09-30$0.00$29.06M$43.02M-$658.00K-$43.01M
2021-06-30$0.00$21.19M$35.38M-$159.00K-$35.31M
2021-03-31$0.00$14.42M$23.40M-$204.00K-$23.13M
2020-09-30$52.00K$4.91M$7.76M$0.00-$7.26M
2020-06-30$42.00K$2.24M$4.63M$0.00-$9.20M
2020-03-31$44.00K$2.01M$3.91M$0.00-$4.09M

Revenue and expense 6 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30(m)(m)$12.59M(m)-$8.50M
2025-06-30(m)(m)$54.00M(m)-$49.59M
2024-06-30(m)$10.18M$38.09M(m)-$39.22M
2023-06-30(m)$29.13M$79.43M$0.00-$75.73M
2022-06-30(m)$80.67M$113.01M-$1.10M-$113.11M
2021-06-30$0.00$35.61M$58.78M-$363.00K-$58.44M
2020-06-30$87.00K$4.25M$8.54M$0.00-$13.29M

Revenue and expense 9 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30(m)(m)$69.02M(m)-$63.18M
2024-09-30(m)(m)$61.72M(m)-$62.24M
2023-09-30(m)$37.62M$146.15M$0.00-$143.16M
2022-09-30(m)$120.33M$169.66M-$1.47M-$169.33M
2021-09-30$0.00$64.67M$101.81M-$1.02M-$101.44M
2020-09-30$138.00K$9.15M$16.30M$0.00-$20.55M

Revenue and expense 12 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31(m)(m)$78.58M$0.00-$71.37M
2024-12-31(m)(m)$73.54M(m)-$74.14M
2023-12-31(m)$39.60M$159.17M$0.00-$156.09M
2022-12-31(m)$141.06M$226.46M-$2.07M-$223.18M
2021-12-31$0.00$107.25M$155.56M$39.00K-$156.79M
2020-12-31$138.00K$19.40M$33.78M$151.00K-$37.74M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tevogen Inc. (TVGN)United States$0.049B
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
Scilex Holding Co (SCLX)United States$0.042B-0.14
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
ImageneBio, Inc. (IMA)United States$0.056B-1.31
BioAtla, Inc. (BCAB)United States$0.058B-0.21
EXOZYMES INC. (EXOZ)United States$0.058B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
aTYR PHARMA INC (ATYR)United States$0.033B-0.98